Cosimo De Nunzio

May 30, 2024 | nature.com | Andrea Mari |Anna Cadenar |Simone Albisinni |Riccardo Autorino |Fabrizio Di Maida |M. Carmen Mir | +6 more

AbstractPositron Emission Tomography-Computed Tomography using Prostate-Specific Membrane Antigen (PSMA PET/CT) is notable for its superior sensitivity and specificity in detecting recurrent PCa and is under investigation for its potential in pre-treatment staging. Despite its established efficacy in nodal and metastasis staging in trial setting, its role in primary staging awaits fuller validation due to limited evidence on oncologic outcomes.

Jan 22, 2024 | nature.com | Cosimo De Nunzio |Riccardo Lombardo

In recent years, several authors have focused on the role of social determinants of health (SDOH) in prostate cancer (PCa), which may have a significant impact on access to treatment and survival rates. The notable advancements in surgical and medical treatments for PCa have, however, exacerbated disparities due to the high costs associated with new diagnostic pathways and therapies. The present clearly represents a gap which needs to be filled.

Feb 4, 2023 | nature.com | Cosimo De Nunzio |Riccardo Lombardo

Prostate cancer (PCa) is the most common cancer among men. Worldwide in 2020, 1,414,259 men were diagnosed of PCa and 375,304 died of PCa. Primary prevention in PCa has always been challenging considering that the three main risk factors (age, ethnicity, and family history) are non-modifiable. Several authors have explored the role of life-style, diet, and physical activity on PCa incidence however results are still controversial.